An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis.

An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis.

Pomel S, Cojean S, Pons V, Cintrat JC, Nguyen L, Vacus J, Pruvost A, Barbier J, Gillet D, Loiseau PM